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Background
Eliciting broadly neutralizing antibodies (bNAbs) to HIV
Env through immunization has been problematic.
Methods
To better understand the requirements for activation of
B cells producing bNAbs, we generated a series of cell
lines and transgenic mice expressing such antibodies or
selected germline-reverted versions as B cell surface
receptors. The bNAb cell lines included those that
recognize the CD4 binding site (b12, VRC01, PGV04,
PGV19, NIH45-46), the MPER of gp41 (4E10), and
additional glycan-dependent sites on the trimer (PG9,
PG16, PGT145, 2G12, PGT128, PGT135, PGT121).
Different Env-containing antigens and virions were
tested for the ability to stimulate bNAb cell lines.
Mouse strains expressing germline or mutated forms
of 4E10 and b12 bNAb Ig genes were generated by gene
targeting to the physiological loci. These “knock-in”
mice were studied for their B cell development, and
responses to HIV immunogens.
Results
Many HIV Env antigen preparations, notably including
infection-competent pseudovirions, were poorly recog-
nized by high affinity bNAb-expressing cells, as mea-
sured by calcium flux assay. However, other antigen
forms were highly stimulatory: in particular, soluble
gp140 foldon trimers and a multimerized, scaffolded
epitope protein.
4E10, but not b12 knock-in mice showed signs of
abortive B cell development. b12 H mice had gp120-
binding cells and responded well in vivo to gp140
trimers.
Conclusion
Analysis of bNAb cell line activation suggested that HIV
is difficult to recognize by B cells, probably because of
the low density of surface proteins. Based on these
results, soluble gp140 trimers or epitope scaffolds might
offer more promise as vaccine candidates. In knock-in
mice, primary 4E10 B cell precursors appeared to be
negatively selected, whereas b12 B cells were normal
and readily stimulated with gp140 trimers.
Author details
1The Scripps Research Institute, La Jolla, CA, USA. 2Frederick National
Laboratory for Cancer Research, Frederick, MD, USA. 3Vaccine Research
Center NIAID, Bethesda, MD, USA. 4Torrey Pines Institute, La Jolla, CA, USA.
5IAVI Neutralizing Antibody Center, USA.
Published: 13 September 2012
doi:10.1186/1742-4690-9-S2-O41
Cite this article as: Nemazee et al.: Engineered mice and B cell lines
expressing broadly neutralizing antibodies and their unmutated
precursors: tools for HIV vaccinology. Retrovirology 2012 9(Suppl 2):O41.
1The Scripps Research Institute, La Jolla, CA, USA
Full list of author information is available at the end of the article
Nemazee et al. Retrovirology 2012, 9(Suppl 2):O41
http://www.retrovirology.com/content/9/S2/O41
© 2012 Nemazee et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
